The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic
A. M. Frankell, S. Jammula, X. Li, G. Contino, S. S. Killcoyne, S. Abbas, J. Perner, L. Bower, G. Devonshire, E. Ococks, N. Grehan, J. Mok, M. O'Donovan, S. Macrae, M. Eldridge, , The Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium
This study identifies 77 driver genes and 21 non-coding driver elements in 551 Esophageal Adenocarcinomas, linking them to clinical outcomes and therapeutic targets.
bioRxiv · Aug 15, 2018Cancer Biology